Immunotherapy market is anticipated to grow at a considerable CAGR of 13.8% during the forecast period. The market growth is mainly driven by increasing auto-immune diseases among adults, growing in monoclonal body production for treatment of cancer, rising approvals for immunotherapies, increasing investments in research and funding of cancer among others. Rising R&D activities in field of the cancer immunotherapy is playing a crucial role in beginning of advanced variants along with elevated efficacy and treatment effectiveness. The R&D in this field will support to medical professionals tomake a shift from chemotherapies that is a traditional one to immunotherapies which is more advanced form of cancer treatment. Therefore, increasing adoption of immunotherapy in replacement of chemotherapy is used to drive the growth of the immunotherapy market..Due to the large scale adoption of sedentary lifestyle, smoking along with alcohol habits are accountable for growing incidence related to cancer. The rising cancer population is creating demand for its treatment; the efficiency of immunotherapy is thus driving the growth of the global immunotherapy market. Additionally, other factors such as technological breakthroughs along with strategic collaborations are again augmenting the growth and development of the market. For instance, in October 2020, Aduro biotech, Inc. had acquired Chinook therapeutics. Aduro biotech, Inc. which emphasis on diseases treatment through discovery, development and commercialization of therapies that will result in harness the body’s natural immune systems while Chinook therapeutics focuses on medicines related to diseases for kidney with particularly emplacing on rare and severe disorders. Through these mergers it will add BION-1301 an investigational anti-APRIL monoclonal antibody which is in its pipeline.
To Request a Sample of our Report on Immunotherapy Market:https://www.omrglobal.com/request-sample/immunotherapy-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Type
- By Application
- By End-User
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape-AbbVie Inc,AstraZeneca,Bristol-Myers Squibb Company,Novartis AG,Merck & Co., Inc.
Immunotherapy Market Report Segment
By Type
- Monoclonal Antibodies
- Cancer Vaccines
- Autoimmune Checkpoint Inhibitors
- Interleukins and Interferons (Cytokinin’s)
- Other
By Application
- Cancer
- Autoimmune and Inflammatory Diseases
- Infectious Diseases
- Other
By End-User
- Hospitals
- Diagnostic Centers
- Other
A full report of Immunotherapy Market is available at: https://www.omrglobal.com/industry-reports/immunotherapy-market
Immunotherapy Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Advaxis, Inc.
- AbbVie Inc.
- AstraZeneca PLC
- Adaptimmune Therapeutics plc.
- Agenus, Inc.
- Atara Biotherapeutics, Inc.
- BellicumPhamaceuticals, Inc.
- Bristol-Myers Squibb Company
- bluebird bio, Inc.
- Chinook Therapeutics, Inc.
- Celldex Therapeutics, Inc.
- CytomX Therapeutics, Inc.
- Gilead Sciences, Inc.
- Incyte Corp.
Reasons to Buy From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404